Tanvex BioPharma, Inc. (TPE: 6541)
Taiwan
· Delayed Price · Currency is TWD
70.90
-0.50 (-0.70%)
Sep 10, 2024, 1:30 PM CST
Tanvex BioPharma Revenue
Tanvex BioPharma had revenue of 17.01M TWD in the quarter ending June 30, 2024, a decrease of -0.43%. This brings the company's revenue in the last twelve months to 34.56M, down -45.54% year-over-year. In the year 2023, Tanvex BioPharma had annual revenue of 61.41M with 174.11% growth.
Revenue (ttm)
34.56M
Revenue Growth
-45.54%
P/S Ratio
286.19
Revenue / Employee
231.93K
Employees
149
Market Cap
11.58B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition